Revvity Net Profit Margin 2010-2025 | RVTY

Current and historical net profit margin for Revvity (RVTY) from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. Revvity net profit margin for the three months ending March 31, 2025 was .
Revvity Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2025-03-31 $2.77B $0.29B 10.32%
2024-12-31 $2.76B $0.27B 9.80%
2024-09-30 $2.72B $0.25B 9.33%
2024-06-30 $2.71B $0.17B 6.24%
2024-03-31 $2.73B $0.15B 5.50%
2023-12-31 $2.75B $0.69B 25.19%
2023-09-30 $2.80B $0.74B 26.54%
2023-06-30 $2.84B $0.82B 28.83%
2023-03-31 $3.02B $0.96B 31.78%
2022-12-31 $3.31B $0.57B 17.18%
2022-09-30 $3.00B $0.63B 21.03%
2022-06-30 $3.15B $0.67B 21.40%
2022-03-31 $3.48B $0.74B 21.28%
2021-12-31 $3.83B $0.94B 24.64%
2021-09-30 $3.63B $1.13B 31.19%
2021-06-30 $3.74B $1.18B 31.65%
2021-03-31 $3.32B $1.07B 32.33%
2020-12-31 $2.66B $0.73B 27.34%
2020-09-30 $3.23B $0.41B 12.77%
2020-06-30 $2.98B $0.30B 9.91%
2020-03-31 $2.89B $0.23B 7.86%
2019-12-31 $2.88B $0.23B 7.91%
2019-09-30 $2.84B $0.23B 8.25%
2019-06-30 $2.80B $0.25B 8.99%
2019-03-31 $2.78B $0.25B 8.88%
2018-12-31 $2.78B $0.24B 8.57%
2018-09-30 $2.66B $0.13B 4.73%
2018-06-30 $2.54B $0.14B 5.51%
2018-03-31 $2.39B $0.28B 11.73%
2017-12-31 $2.26B $0.29B 12.98%
2017-09-30 $2.18B $0.40B 18.29%
2017-06-30 $2.14B $0.37B 17.09%
2017-03-31 $2.13B $0.23B 10.61%
2016-12-31 $2.12B $0.23B 11.06%
2016-09-30 $2.00B $0.24B 11.86%
2016-06-30 $2.05B $0.23B 11.43%
2016-03-31 $2.08B $0.22B 10.55%
2015-12-31 $2.11B $0.21B 10.07%
2015-09-30 $2.10B $0.18B 8.35%
2015-06-30 $2.07B $0.16B 7.81%
2015-03-31 $2.07B $0.16B 7.89%
2014-12-31 $2.07B $0.16B 7.58%
2014-09-30 $2.22B $0.19B 8.70%
2014-06-30 $2.20B $0.19B 8.69%
2014-03-31 $2.18B $0.17B 7.74%
2013-12-31 $2.16B $0.17B 7.74%
2013-09-30 $2.13B $0.08B 3.94%
2013-06-30 $2.12B $0.07B 3.49%
2013-03-31 $2.10B $0.08B 3.81%
2012-12-31 $2.11B $0.07B 3.37%
2012-09-30 $2.08B $0.00B 0.14%
2012-06-30 $2.03B $0.01B 0.49%
2012-03-31 $1.98B $0.01B 0.30%
2011-12-31 $1.92B $0.01B 0.42%
2011-09-30 $1.85B $0.39B 21.02%
2011-06-30 $1.81B $0.36B 20.09%
2011-03-31 $1.76B $0.39B 22.34%
2010-12-31 $1.70B $0.39B 22.97%
2010-09-30 $1.54B $0.13B 8.53%
2010-06-30 $1.49B $0.13B 8.84%
2010-03-31 $1.51B $0.10B 6.36%
2009-12-31 $1.55B $0.08B 5.35%
Sector Industry Market Cap Revenue
Medical Medical Services $11.635B $2.755B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $142.869B 26.80
CVS Health (CVS) United States $84.351B 10.48
Elevance Health (ELV) United States $78.372B 10.11
Cencora (COR) United States $58.632B 20.40
DiDi Global (DIDIY) China $23.485B 24.95
Natera (NTRA) United States $21.669B 0.00
Labcorp Holdings (LH) United States $21.584B 17.51
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.511B 0.00
Solventum (SOLV) United States $13.191B 13.96
CochLear (CHEOY) Australia $12.755B 0.00
ICON (ICLR) Ireland $11.919B 11.08
Viatris (VTRS) United States $10.798B 3.71
Avantor (AVTR) United States $9.206B 13.38
Medpace Holdings (MEDP) United States $9.166B 24.34
HealthEquity (HQY) United States $8.806B 38.57
Sonic Healthcare (SKHHY) Australia $8.474B 0.00
Charles River Laboratories (CRL) United States $7.559B 14.81
Caris Life Sciences,�Inc (CAI) United States $6.749B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.885B 28.77
BrightSpring Health Services (BTSG) United States $3.868B 35.48
Sotera Health (SHC) United States $3.236B 18.39
Surgery Partners (SGRY) United States $2.823B 36.72
Concentras Parent (CON) United States $2.608B 15.07
Alignment Healthcare (ALHC) United States $2.600B 0.00
Organon (OGN) United States $2.527B 2.69
GeneDx Holdings (WGS) United States $2.446B 94.22
Ardent Health (ARDT) United States $1.902B 8.11
PACS (PACS) United States $1.902B 0.00
Progyny (PGNY) United States $1.839B 40.47
Premier (PINC) United States $1.812B 13.75
GoodRx Holdings (GDRX) United States $1.693B 33.86
Teladoc Health (TDOC) United States $1.416B 0.00
Establishment Labs Holdings (ESTA) $1.333B 0.00
Pediatrix Medical (MD) United States $1.155B 8.79
CareDx (CDNA) United States $1.027B 16.04
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.965B 0.00
AMN Healthcare Services Inc (AMN) United States $0.813B 7.61
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Nutex Health (NUTX) United States $0.698B 10.57
Embecta (EMBC) United States $0.586B 3.95
InnovAge Holding (INNV) United States $0.563B 0.00
LifeMD (LFMD) United States $0.554B 0.00
Omada Health (OMDA) $0.481B 0.00
SBC Medicals (SBC) United States $0.467B 0.00
Sonida Senior Living (SNDA) United States $0.466B 0.00
Auna S.A (AUNA) Luxembourg $0.464B 10.45
So-Young (SY) China $0.436B 0.00
Enhabit (EHAB) United States $0.371B 30.50
Performant Healthcare (PHLT) United States $0.329B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.310B 0.00
Beauty Health (SKIN) United States $0.277B 0.00
Oncology Institute (TOI) United States $0.228B 0.00
DocGo (DCGO) United States $0.155B 25.33
Pheton Holdings (PTHL) China $0.129B 0.00
Sera Prognostics (SERA) United States $0.091B 0.00
KindlyMD (NAKA) United States $0.073B 0.00
Ascend Wellness Holdings (AAWH) United States $0.065B 0.00
IceCure Medical (ICCM) Israel $0.062B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
OpGen (OPGN) United States $0.051B 0.00
ModivCare (MODV) United States $0.047B 0.00
Biodesix (BDSX) United States $0.040B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.036B 0.00
Basel Medical Group (BMGL) Singapore $0.035B 0.00
OSR Holdings (OSRH) United States $0.026B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
BioNexus Gene Lab (BGLC) $0.011B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.005B 0.00
NewGenIvf Group (NIVF) Thailand $0.004B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00